NCT02673606View on ClinicalTrials.gov

Impact of Estrogen on Fear Extinction R61

PHASE1CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 15, 2019

Study Completion Date

April 15, 2019

Conditions
FearFear; Examination, Phobic
Interventions
DRUG

Estradiol 2Mg Tablet

one 2 mg dose of estradiol (obtained from Estrace® Tablets, 2.0 mg estradiol tablets, USP, Warner Chilcott),

DRUG

Estradiol 4Mg Tablet

two 2 mg pills estradiol(obtained from Estrace® Tablets, 2.0 mg estradiol tablets, USP, Warner Chilcott),

DRUG

Placebo Pills

inactive placebo pills

Trial Locations (1)

10016

NYU School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02673606 - Impact of Estrogen on Fear Extinction R61 | Biotech Hunter | Biotech Hunter